Cadwalader allows sharing content.
Email to a friend or colleague:
From
To
Subject
Email Cadwalader Intellectual Property Group partner John Moehringer participated in a panel discussion last week at the annual policy meeting of the Global Intellectual Property committee of the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents the country’s leading innovative biopharmaceutical research companies. https://www.cadwalader.com/news/news-release/cadwaladers-john-moehringer-presents-on-artificial-intelligence-at-annual-policy-meeting-of-phrmas-global-ip-committee-